Lumiliximab, CAS 357613-86-6

Product Description: Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Poole JA, et al. Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J Allergy Clin Immunol. 2005 Oct;116(4):780-8.

CAS Number: 357613-86-6

Molecular Weight: 47.75 (kDa)

Compound Purity: 99.82

Research Area: Inflammation/Immunology

Solubility: H2O

Target: Others

• Artikelnummer: MEXHY-P99303-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99303-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK